Last viewed:
DGX
Prices are updated after-hours
DGX
|
News
|
$137.55
0.62%
0.0%
1.6M
|
Health Services
(0.0% 1d)
(6.7% 1m)
(-6.3% 1y)
(0.0% 2d)
(0.6% 3d)
(7.1% 7d)
(-24.98%
volume)
Earnings Calendar: 2024-02-01
Market Cap: $ 15,275,761,741
http://www.questdiagnostics.com
Sec
Filling
|
Patents
| 47000 employees
(US) Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
clinical trials
diagnostics
information technology
add to watch list
Paper trade
email alert is off
Press-releases
Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024
Published: 2024-04-23
(Crawled : 12:00)
- biospace.com/
DGX
|
News
|
$137.55
0.62%
0.0%
1.6M
|
Health Services
| 6.74%
| O: 4.76%
H: 2.9%
C: 1.26%
first
year
for
diagnostics
financial
Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease
Published: 2024-04-22
(Crawled : 14:00)
- biospace.com/
DGX
|
News
|
$137.55
0.62%
0.0%
1.6M
|
Health Services
| 7.09%
| O: 0.33%
H: 0.0%
C: 0.0%
disease
services
biomarker
blood
risk
alzheimer's
diagnostics
Toxicology Testing Market size is set to grow by USD 32.58 billion from 2024-2028, High regulatory compliance in food industry boost the market, Technavio
Published: 2024-04-11
(Crawled : 02:00)
- prnewswire.com
WAT
|
$310.25
-0.97%
0.0%
530K
|
Health Technology
| -7.81%
| O: 1.5%
H: 0.23%
C: -1.07%
TMO
|
News
|
$577.39
0.49%
0.0%
2M
|
Health Technology
| 0.01%
| O: 0.07%
H: 0.0%
C: 0.0%
DGX
|
News
|
$137.55
0.62%
0.0%
1.6M
|
Health Services
| 3.85%
| O: -0.13%
H: 0.2%
C: -1.71%
LH
4
|
$207.94
-0.01%
0.0%
790K
|
Health Services
| -1.36%
| O: -0.61%
H: 0.02%
C: -0.68%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
| -3.85%
| O: 0.43%
H: 0.3%
C: -0.18%
food
set
market
Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay
Published: 2024-04-02
(Crawled : 15:30)
- biospace.com/
DGX
|
News
|
$137.55
0.62%
0.0%
1.6M
|
Health Services
| 2.06%
| O: -0.13%
H: 0.0%
C: -1.72%
test
genetic
diagnostics
Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease
Published: 2024-03-26
(Crawled : 12:00)
- biospace.com/
DGX
|
News
|
$137.55
0.62%
0.0%
1.6M
|
Health Services
| 6.4%
| O: 0.26%
H: 0.1%
C: -0.58%
disease
test
blood
alzheimer's
imaging
study
Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024
Published: 2024-03-19
(Crawled : 22:00)
- biospace.com/
DGX
|
News
|
$137.55
0.62%
0.0%
1.6M
|
Health Services
| 7.34%
| O: 0.12%
H: 1.28%
C: 0.59%
first
diagnostics
financial
results
Global Respiratory Syncytial Virus Diagnostics Market Report 2024-2029: Rising Healthcare Expenditure, Technological Innovations, and Increased Incidence of RSV Fueling Growth
Published: 2024-03-05
(Crawled : 05:00)
- prnewswire.com
TMO
|
News
|
$577.39
0.49%
0.0%
2M
|
Health Technology
| -0.73%
| O: -0.09%
H: 0.86%
C: 0.6%
DGX
|
News
|
$137.55
0.62%
0.0%
1.6M
|
Health Services
| 9.77%
| O: 0.38%
H: 0.69%
C: -1.01%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
| -3.55%
| O: 0.32%
H: 0.22%
C: -0.2%
BIO
|
$278.21
-2.48%
0.0%
210K
|
Health Technology
| -16.87%
| O: -0.53%
H: 1.08%
C: -0.59%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
| -9.81%
| O: 1.6%
H: 0.0%
C: 0.0%
QDEL
|
News
4
|
$40.81
1.02%
1.0%
940K
|
Health Technology
| -7.92%
| O: 0.18%
H: 1.13%
C: -3.31%
report
respiratory
global
rsv
virus
diagnostics
growth
market
Next Generation Sequencing Services Markets, 2030 - Substantial Growth with Emphasis on Oncology and Reproductive Applications
Published: 2024-03-01
(Crawled : 19:00)
- prnewswire.com
ILMN
|
$122.74
-1.38%
-1.4%
1.2M
|
Health Technology
| Email alert
Add to watchlist
QGEN
|
$41.52
-0.88%
0.0%
820K
|
Health Technology
| Email alert
Add to watchlist
NVTA
|
News
|
$0.019
0.0%
22M
|
Health Services
| Email alert
Add to watchlist
PKI
|
$115.24
0.0%
1.6M
|
Health Technology
| Email alert
Add to watchlist
QGEN
|
$41.52
-0.88%
0.0%
820K
|
Health Technology
| Email alert
Add to watchlist
DGX
|
News
|
$137.55
0.62%
0.0%
1.6M
|
Health Services
| Email alert
Add to watchlist
SQL
|
$6.5991
-29.23%
22K
|
| Email alert
Add to watchlist
services
growth
Quest Diagnostics to Speak at the Barclays 26th Annual Global Healthcare Conference
Published: 2024-02-23
(Crawled : 15:00)
- prnewswire.com
CART
4
|
$34.26
2.51%
2.45%
4.1M
|
| 14.73%
| O: 3.75%
H: 3.84%
C: -1.32%
DGX
|
News
|
$137.55
0.62%
0.0%
1.6M
|
Health Services
| 9.74%
| O: 0.32%
H: 1.18%
C: 1.07%
conference
global
diagnostics
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
Published: 2024-02-15
(Crawled : 12:00)
- biospace.com/
DGX
|
News
|
$137.55
0.62%
0.0%
1.6M
|
Health Services
| 7.7%
| O: 0.22%
H: 0.7%
C: -1.77%
million
cancer
funding
platform
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001022079-24-000089
4
2024-03-28
2024-03-26
Sell
F
170
5433
0001022079-24-000088
4
2024-03-28
2024-03-26
Sell
F
114
15981
0001022079-24-000085
4
2024-03-01
2024-02-28
Sell
F
105
16082
0001022079-24-000085
4
2024-03-01
2024-02-28
Sell
F
228
16187